| Tretinoin | Approved Investigational Nutraceutical | ATXN1 | 6310 |
upregulated | Tretinoin results in increased expression of ATXN1 mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATXN7L3B | 552889 |
downregulated | Tretinoin results in decreased expression of ATXN7L3B mRNA | 12q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AURKAIP1 | 54998 |
downregulated | Tretinoin results in decreased expression of AURKAIP1 mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | AURKB | 9212 |
downregulated | Tretinoin results in decreased expression of AURKB mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AUTS2 | 26053 |
upregulated | Tretinoin results in increased expression of AUTS2 mRNA | 7q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | AVIL | 10677 |
upregulated | Tretinoin results in increased expression of AVIL mRNA | 12q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AXIN1 | 8312 |
upregulated | Tretinoin results in increased expression of AXIN1 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AZIN1 | 51582 |
downregulated | Tretinoin results in decreased expression of AZIN1 mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AZIN2 | 113451 |
upregulated | Tretinoin results in increased expression of AZIN2 mRNA | 1p35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AZU1 | 566 |
downregulated | Tretinoin results in decreased expression of AZU1 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AZU1 | 566 |
upregulated | Tretinoin results in increased expression of AZU1 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | B2M | 567 |
upregulated | Tretinoin results in increased expression of B2M mRNA | 15q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GALNT1 | 8706 |
upregulated | Tretinoin results in increased expression of B3GALNT1 mRNA | 3q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GALT4 | 8705 |
upregulated | Tretinoin results in increased expression of B3GALT4 mRNA | 6p21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GAT1 | 27087 |
downregulated | Tretinoin results in decreased expression of B3GAT1 mRNA | 11q25 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GAT2 | 135152 |
downregulated | Tretinoin results in decreased expression of B3GAT2 mRNA | 6q13 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GNT7 | 93010 |
upregulated | Tretinoin results in increased expression of B3GNT7 mRNA | 2q37.1 | |
| Tretinoin | Approved Investigational Nutraceutical | B3GNT9 | 84752 |
upregulated | Tretinoin results in increased expression of B3GNT9 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | B4GALT1 | 2683 |
upregulated | Tretinoin results in increased expression of B4GALT1 mRNA | 9p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | B4GALT5 | 9334 |
upregulated | Tretinoin results in increased expression of B4GALT5 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | BAALC | 79870 |
upregulated | Tretinoin results in increased expression of BAALC mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BACE1 | 23621 |
upregulated | Tretinoin results in increased expression of BACE1 mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BAG2 | 9532 |
upregulated | Tretinoin results in increased expression of BAG2 mRNA | 6p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BAHCC1 | 57597 |
downregulated | Tretinoin results in decreased expression of BAHCC1 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BAIAP2L2 | 80115 |
downregulated | Tretinoin results in decreased expression of BAIAP2L2 mRNA | 22q13.1 | |